⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8632964 | 0.82 | — | — | |
| SCHEMBL65107 | 0.81 | CA12 (0.61) | — | |
| SCHEMBL452901 | 0.80 | NAAA (0.40) | — | |
| Citric Acid SCHEMBL8772054 | 0.80 | ALDH1A1 (0.50) | — | |
| SCHEMBL12589581 | 0.79 | CA12 (0.59) | — | |
| SCHEMBL196815 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL8143027 | 0.77 | CA12 (0.57) | — | |
| Hydrochloric Acid SCHEMBL1876862 | 0.77 | CA12 (0.57) | — | |
| Iodide SCHEMBL30042709 | 0.77 | CA12 (0.57) | — | |
| SCHEMBL708934 | 0.77 | CA12 (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3464505-B1 | SHEAR RECOVERY FOR VISCOSIFYING SURFACTANTS IN STIMULATION FLUIDS | ENERGY SOLUTIONS US LLC (US) | 2023-07-19 | — | — | EP | disclosed |
| EP-3917574-A1 | IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY TO THE LUNG | The Board of Trustees of the Leland Stanford Junior University (US) | 2021-12-08 | — | — | EP | disclosed |
| WO-2020160511-A1 | IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY TO THE LUNG | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2020-08-06 | — | — | WO | disclosed |
| EP-3490562-A1 | IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY | The Board of Trustees of the Leland Stanford Junior University (US) | 2019-06-05 | — | — | EP | disclosed |
| EP-3464505-A1 | SHEAR RECOVERY FOR VISCOSIFYING SURFACTANTS IN STIMULATION FLUIDS | Rhodia Operations (FR) | 2019-04-10 | — | — | EP | disclosed |
| CN-108853607-A | A kind of insulin needle surface siliconization inorganic agent | 广州市爱创医疗科技有限公司 | 2018-11-23 | — | — | CN | disclosed |
| CN-108718522-A | IL-6 antagonist formulations and application thereof | 赛森生物股份有限公司 | 2018-10-30 | — | — | CN | disclosed |
| CN-108473484-A | Compounds useful as TRPM8 modulators | 赛诺米克斯公司 | 2018-08-31 | — | — | CN | disclosed |
| WO-2018022930-A1 | IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2018-02-01 | — | — | WO | disclosed |
| WO-2017205599-A1 | SHEAR RECOVERY FOR VISCOSIFYING SURFACTANTS IN STIMULATION FLUIDS | RHODIA OPERATIONS (FR) | 2017-11-30 | — | — | WO | disclosed |
| EP-2408751-B1 | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof | BAYER IP GMBH (DE) | 2017-08-23 | — | — | EP | disclosed |
| EP-2555845-A1 | RECOVERY AND SEPARATION OF CRUDE OIL AND WATER FROM EMULSIONS | William Marsh Rice University (US) | 2013-02-13 | — | — | EP | disclosed |
| EP-2408751-A1 | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof | Bayer Pharma Aktiengesellschaft (DE) | 2012-01-25 | — | — | EP | disclosed |
| WO-2011126964-A1 | RECOVERY AND SEPARATION OF CRUDE OIL AND WATER FROM EMULSIONS | WILLIAM MARSH RICE UNIVERSITY (US) | 2011-10-13 | — | — | WO | disclosed |
| WO-2010105770-A1 | SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-09-23 | — | — | WO | disclosed |
| EP-1235647-A1 | ESTERIFICATION CATALYST COMPOSITIONS AND USE THEREOF | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-09-04 | — | — | EP | disclosed |
| WO-2001039885-A1 | ESTERIFICATION CATALYST COMPOSITIONS AND USE THEREOF | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-06-07 | — | — | WO | disclosed |
| US-5475023-A | Treatment of allergic conditions of eye, nose, lungs, gastrointestinal tract | FISONS PLC (GB) | 1995-12-12 | — | — | US | disclosed |
| EP-0587264-B1 | Aqueous pharmaceutical formulations of sodium cromoglycate | FISONS PLC (GB) | 1994-10-26 | — | — | EP | disclosed |
| EP-0587264-A1 | Aqueous pharmaceutical formulations of sodium cromoglycate | FISONS plc (GB) | 1994-03-16 | — | — | EP | disclosed |